EGFR and central nervous system cancer: In future studies, we will develop an ensemble model that integrates multiple gene signatures designed for different subgroups of glioma patients stratified by molecular subtypes or major genomic mutations in IDH1, CIMP, EGFR and PTEN in glioma cohorts to further improve the predictive accuracy.